|
DE19604920A1
(de)
*
|
1996-02-01 |
1997-08-07 |
Schering Ag |
Neue 2,3-Benzodiazepinderivate, deren Herstellung und Verwendung als Arzneimittel
|
|
DE19604919A1
(de)
|
1996-02-01 |
1997-08-07 |
Schering Ag |
Neue 2,3-Benzodiazepinderivate, deren Herstellung und Verwendung als Arzneimittel
|
|
US6635632B1
(en)
*
|
1996-12-23 |
2003-10-21 |
Athena Neurosciences, Inc. |
Cycloalkyl, lactam, lactone and related compounds, pharmaceutical compositions comprising same, and methods for inhibiting β-amyloid peptide release and/or its synthesis by use of such compounds
|
|
HU227128B1
(en)
*
|
1999-07-07 |
2010-07-28 |
Egyt Gyogyszervegyeszeti Gyar |
New 2,3-benzodiazepine derivatives
|
|
DE10004572A1
(de)
*
|
2000-02-02 |
2001-08-09 |
Boehringer Ingelheim Pharma |
Neue positive allosterische AMPA-Rezeptor Modulatoren (PAARM), Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel
|
|
NZ522773A
(en)
|
2000-06-12 |
2005-06-24 |
Eisai Co Ltd |
1,2-dihydropyridine compounds, manufacturing method thereof and use thereof
|
|
US6432944B1
(en)
|
2000-07-06 |
2002-08-13 |
Bristol-Myers Squibb Company |
Benzodiazepinone β-amyloid inhibitors: arylacetamidoalanyl derivatives
|
|
HU225100B1
(hu)
*
|
2000-12-21 |
2006-06-28 |
Egyt Gyogyszervegyeszeti Gyar |
2,3-Benzodiazepinszármazékok, ilyen hatóanyagot tartalmazó gyógyászati készítmények és alkalmazásuk
|
|
US6649607B2
(en)
*
|
2001-05-18 |
2003-11-18 |
Vela Pharmaceuticals, Inc. |
Compositions and methods for treating or preventing convulsions or seizures
|
|
US7250410B2
(en)
|
2001-06-07 |
2007-07-31 |
Via Pharmaceuticals, Inc. |
Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses thereof
|
|
GB0129260D0
(en)
|
2001-12-06 |
2002-01-23 |
Eisai London Res Lab Ltd |
Pharmaceutical compositions and their uses
|
|
US7022700B2
(en)
*
|
2002-12-03 |
2006-04-04 |
Vela Pharmaceuticals, Inc. |
Method of increasing neutrophil production using optically-pure (R)-2,3-benzodiazepines
|
|
CA2508542A1
(en)
*
|
2002-12-03 |
2004-06-17 |
Vela Pharmaceuticals, Inc. |
Pharmaceutical composition of 1-(3,4-dimethoxyphenyl)-4-methyl-5-ethyl-7-methoxy-8-hydroxy-5h-2,3-benzodiazepine and uses thereof
|
|
US6638928B1
(en)
|
2002-12-03 |
2003-10-28 |
Vela Pharmaceuticals, Inc. |
Treatment of irritable bowel syndrome and nonulcer dyspepsia with substituted 2,3-benzodiazepines
|
|
JP2006514084A
(ja)
*
|
2002-12-03 |
2006-04-27 |
ヴェラ ファーマスーティカルズ インコーポレイテッド |
１−（３−ヒドロキシ−４−メトキシフェニル）−４−メチル−５−エチル−７，８−ジメトキシ−５ｈ−２，３−ベンゾジアゼピンの製薬組成物及びその用途
|
|
US6864251B2
(en)
*
|
2002-12-03 |
2005-03-08 |
Vela Pharmaceuticals, Inc. |
Treatment of LTB4-mediated inflammatory disorders with optically-pure (R)-2,3-benzodiazepines
|
|
WO2004062616A2
(en)
|
2003-01-13 |
2004-07-29 |
Cortex Pharmaceuticals, Inc. |
Method of treating cognitive decline due to sleep deprivation and stress
|
|
US20040152694A1
(en)
*
|
2003-02-04 |
2004-08-05 |
Istvan Kurucz |
Methods and compositions for treating inflammatory disorders of the airways
|
|
US20040224943A1
(en)
*
|
2003-02-19 |
2004-11-11 |
Leventer Steven M. |
Method of lowering body temperature with (R) - 2,3-benzodiazepines
|
|
US20040162284A1
(en)
*
|
2003-02-19 |
2004-08-19 |
Harris Herbert W. |
Method of lowering body temperature with (S) tofisopam
|
|
GB0325175D0
(en)
*
|
2003-10-28 |
2003-12-03 |
Novartis Ag |
Organic compounds
|
|
MY148809A
(en)
|
2004-07-06 |
2013-05-31 |
Eisai R&D Man Co Ltd |
Crystals of 1,2-dihydropyridine compound and their production process
|
|
JP2007153755A
(ja)
*
|
2005-12-01 |
2007-06-21 |
Gifu Univ |
プロリン類縁体
|
|
EP2338492A1
(en)
|
2009-12-24 |
2011-06-29 |
Universidad del Pais Vasco |
Methods and compositions for the treatment of alzheimer
|
|
FR2972454B1
(fr)
*
|
2011-03-08 |
2013-03-01 |
Servier Lab |
Nouveaux derives dihydro-oxazolobenzodiazepinones, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
|
|
ES2628005T3
(es)
|
2012-08-16 |
2017-08-01 |
Bayer Pharma Aktiengesellschaft |
2,3-Benzodiazepinas
|
|
CN105263919A
(zh)
|
2013-02-19 |
2016-01-20 |
拜耳医药股份有限公司 |
二环2,3-苯并二氮杂*和螺环取代的2,3-苯并二氮杂*
|
|
JP2016513117A
(ja)
|
2013-02-22 |
2016-05-12 |
バイエル ファーマ アクチエンゲゼルシャフト |
過剰増殖性疾患を治療するためのｂｅｔタンパク質阻害剤としてのピロロ−およびピラゾロ−トリアゾロジアゼピン類
|
|
WO2014128111A1
(de)
|
2013-02-22 |
2014-08-28 |
Bayer Pharma Aktiengesellschaft |
4-substituierte pyrrolo- und pyrazolo-diazepine
|
|
US20150011554A1
(en)
|
2013-06-13 |
2015-01-08 |
Veroscience Llc |
Compositions and Methods for Treating Metabolic Disorders
|
|
WO2020124090A1
(en)
|
2018-12-14 |
2020-06-18 |
Eisai R&D Management Co., Ltd. |
Aqueous based pharmaceutical formulations of 1,2-dihydropyridine compounds
|